# Viking Therapeutics Inc. (VKTX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $34.87, market value $4.1 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Viking Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 10.0×**. The shares trade at 10.0× book value; most of the value is in earnings power and intangibles rather than the balance sheet.

## Profitability
- **Return on equity: -56.3%**. Return on equity is negative because earnings are negative.
- **Return on assets: -74.7%**. Each dollar of assets produces -74.7% of profit.

## Growth
- **EPS growth (1 yr): -215.8%**. Earnings per share fell 215.8%.

## Financial health
- **Current ratio: 9.33** (quick 9.33). Current assets cover the next year's liabilities 9.33 times.
- **Altman Z-score: 32.34**. A Z-score of 32.34 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 1/9**. 1 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Viking Therapeutics Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (19 analysts). 19 analysts cover Viking Therapeutics Inc.; the consensus is strong_buy, with an average price target of $92.39 (+165% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 31.4%** (YTD -0.9%, 3-mo 22.6%). The shares are up 31.4% over twelve months including dividends.
- **From 52-week high: -19.2%** (51.9% above the low). Trading 19% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 54**. An RSI of 54 is neutral.
- **Beta (1 yr): 1.31** (volatility 60%). Beta of 1.31 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=VKTX · Page: https://foliofundamentals.com/stocks/vktx

Not investment advice.